Showing results (641-650 of 1,256) with videos related to
Sort By:
Pageof 126
Neuroimmunomodulation|October 7, 2004
The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosisClaus G Haase, Michael Tinnefeld, Pedro M FaustmannNeuroimmunomodulation|October 7, 2004
The role of asymmetry of nervous and immune systems in the formation of cellular immunity of (CBaxC57Bl/6) F1 miceIrina A Gontova, Valery V Abramov, Vladimir A KozlovNeuroimmunomodulation|October 7, 2004
Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal ratsKlára Felszeghy, Ghazal Banisadr, William Rostène, et al.Neuroimmunomodulation|July 14, 2004
Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2)Costas Phenekos, Andromachi Vryonidou, Angelos D Gritzapis, et al.Neuroimmunomodulation|July 14, 2004
Differential responses of circulating prolactin, GH, and ACTH levels and distribution and activity of submaxillary lymph node lymphocytes to calorie restriction in male Lewis and Wistar ratsSara Lopez-Varela, Fernando Chacón, Pilar Cano, et al.Neuroimmunomodulation|July 14, 2004
Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing studyYehuda Shavit, Shamgar Ben-Eliyahu, Alexander Zeidel, et al.Neuroimmunomodulation|July 14, 2004
Benign multiple sclerosis is characterized by a stable neuroimmunologic networkClaus G Haase, Pedro M FaustmannNeuroimmunomodulation|April 7, 2004
Pharmacological hyperprolactinemia attenuates hydrocortisone-induced expression of CD11b on human CD8+ cells in vivoRichard Imrich, Elena Tibenska, Juraj Koska, et al.Neuroimmunomodulation|April 7, 2004
Modulation of delayed-type hypersensitivity responses in hairless guinea pigs by peptides derived from enkephalinRobert C Sizemore, Marta Piva, LeeTerry Moore, et al.Neuroimmunomodulation|April 7, 2004
Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failureJulia R Gage, Gregg Fonarow, Michele Hamilton, et al.Pageof 126